Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
An international group of experts in pharmacokinetic modeling recommends a consensus nomenclature to describe in vivo molecular imaging of reversibly binding radioligands.
Innis
Robert B
RB
National Institute of Mental Health, Molecular Imaging Branch, Bethesda, Maryland, USA. robert.innis@nih.gov
Cunningham
Vincent J
VJ
Delforge
Jacques
J
Fujita
Masahiro
M
Gjedde
Albert
A
Gunn
Roger N
RN
Holden
James
J
Houle
Sylvain
S
Huang
Sung-Cheng
SC
Ichise
Masanori
M
Iida
Hidehiro
H
Ito
Hiroshi
H
Kimura
Yuichi
Y
Koeppe
Robert A
RA
Knudsen
Gitte M
GM
Knuuti
Juhani
J
Lammertsma
Adriaan A
AA
Laruelle
Marc
M
Logan
Jean
J
Maguire
Ralph Paul
RP
Mintun
Mark A
MA
Morris
Evan D
ED
Parsey
Ramin
R
Price
Julie C
JC
Slifstein
Mark
M
Sossi
Vesna
V
Suhara
Tetsuya
T
Votaw
John R
JR
Wong
Dean F
DF
Carson
Richard E
RE
D003952:Diagnostic Imaging / Q000592:standards*; D049268:Positron-Emission Tomography; D011869:Radioligand Assay / Q000592:standards*; D019275:Radiopharmaceuticals; D009626:Terminology as Topic; D015899:Tomography, Emission-Computed, Single-Photon
D019275:Radiopharmaceuticals